share_log

Coya Therapeutics, Inc. Highlights Publication Of An Article Titled 'Ex Vivo Expanded Human Regulatory T Cells Modify Neuroinflammation in a Preclinical Model of Alzheimer's Disease'

Benzinga Real-time News ·  Jan 26, 2023 22:03
Coya Therapeutics, Inc. Highlights Publication Of An Article Titled 'Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer's Disease'
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment